IL181958A - Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound - Google Patents

Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound

Info

Publication number
IL181958A
IL181958A IL181958A IL18195807A IL181958A IL 181958 A IL181958 A IL 181958A IL 181958 A IL181958 A IL 181958A IL 18195807 A IL18195807 A IL 18195807A IL 181958 A IL181958 A IL 181958A
Authority
IL
Israel
Prior art keywords
compound
gene
regulating
expression
pharmaceutical composition
Prior art date
Application number
IL181958A
Other languages
Hebrew (he)
Other versions
IL181958A0 (en
Original Assignee
Quark Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2005/001035 external-priority patent/WO2006035434A2/en
Application filed by Quark Pharmaceuticals Inc filed Critical Quark Pharmaceuticals Inc
Priority to IL181958A priority Critical patent/IL181958A/en
Publication of IL181958A0 publication Critical patent/IL181958A0/en
Publication of IL181958A publication Critical patent/IL181958A/en

Links

IL181958A 2004-09-28 2007-03-15 Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound IL181958A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL181958A IL181958A (en) 2004-09-28 2007-03-15 Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61399104P 2004-09-28 2004-09-28
US65819605P 2005-03-02 2005-03-02
US70302005P 2005-07-26 2005-07-26
PCT/IL2005/001035 WO2006035434A2 (en) 2004-09-28 2005-09-27 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
IL181958A IL181958A (en) 2004-09-28 2007-03-15 Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound

Publications (2)

Publication Number Publication Date
IL181958A0 IL181958A0 (en) 2007-07-04
IL181958A true IL181958A (en) 2016-02-29

Family

ID=42333889

Family Applications (1)

Application Number Title Priority Date Filing Date
IL181958A IL181958A (en) 2004-09-28 2007-03-15 Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound

Country Status (1)

Country Link
IL (1) IL181958A (en)

Also Published As

Publication number Publication date
IL181958A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
IL194290A (en) Rna complex comprising a core double stranded region, a pharmaceutical compound comprising the same, a methof for preparing the same and uses thereof
IL181248A (en) Pharmaceutical composition comprising an antibiotic, a triazole and a corticosteroid
IL163670A0 (en) Method of using modified oligonucleotides for hepatic delivery
AU2003295387A1 (en) Modified oligonucleotides for use in rna interference
ZA200705951B (en) Hydroprocessing catalyst, preparation method thereof and use of same
IL223477A (en) Pharmaceutical composition comprising modified uricase
EP1862158B8 (en) A pharmaceutical composition for treating depression and method for preparation thereof
EP1765373A4 (en) Ozonidzed pharmaceutical composition and method
IL193699A0 (en) Proteins, nucleic acids and medicaments
AU2003299864A1 (en) Sirna compounds and methods for the downregulation of gene expression
PL1791872T3 (en) Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof
AU2005270917A8 (en) Gastrin-specific interfering RNA
EP1711490A4 (en) Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same
IL181958A (en) Double stranded rna compound for down-regulating the expression of gene p53, a pharmaceutical composition comprising said compound and use and method of use of said compound
IL175293A0 (en) Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof
IL209656A (en) Double stranded rna compound, pharmaceutical composition comprising said compound and use of said compound
AU2003222173A1 (en) Nucleic acid compositions and methods for use
GB0406836D0 (en) Expression cell lines employing RNA trans-splicing
AU2003283374A1 (en) Pharmaceutical composition for suppressing undesired gene expression
AU2004901310A0 (en) RNA hairpin expressing sequences-II
IL188501A0 (en) Nucleic acid agents for downregulating h19, and method of using same
AU2005905465A0 (en) Method of Drug Design
AU2005900493A0 (en) Pharmaceutical compounds and methods
EP1811022A4 (en) Arylacylamidase gene and method of using the same
PL368024A1 (en) New 9,9 -dihexadecylfluorene and method for its manufacture

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed